1. Chérin P (2004) Intravenous immunoglobulin in polymyositis and dermatomyositis. In: Dalakas C, Späth JP (eds) Intravenous immunoglobulins in the third millennium. The Parthenon Publishing Group, USA, UK, pp 207–211
2. Dalakas MC, Pongratz D (2003) Inflammatory myopathies. In: Brandt Th, Caplan LR, Dichgans J, Diener HC, Kennard C (eds) Neurological disorders. Second Edition, Academic Press, Elsevier Sience (USA), Chapter 95, pp 1363–1368
3. Dalakas MC (2004) Controlled studies with high-doses intravenous immunoglobulin in the treatment of inclusion body myositis. In: Dalakas C, Späth JP (eds) Intravenous immunoglobulins in the third millennium. The Parthenon Publishing Group, USA, UK, pp 207–211
4. Pongratz D, Walter MC (2002) Dermatomyositis/polymyositis—diagnostic criteria and therapeutic aspects. In: Kiehl MG, Nass WP, Volk H-D (eds) Immunomodulation with immunoglobulins for autoimmune diseases and infections. Georg Thieme Verlag Stuttgart, pp 84–90